公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2012 | A phase I/II study of foretinib, an oral multikinase inhibitor targeting MET, RON, AXL, TIE-2, and VEGFR in advanced hepatocellular carcinoma (HCC). | Yau, Thomas Cheung; Sukeepaisarnjaroen, Wattana; Chao, Yee; Yen, Chia-Jui; Lausoontornsiri, Wirote; Chen, Pei-Jer; Sanpajit, Theeranun; Lencioni, Riccardo; Camp, Aaron C.; Cox, Donna S.; Kallender, Howard; Ottesen, Lone Harild; Poon, Ronnie Tung-Ping | J. Clin. Oncol. |